These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19726405)

  • 41. Multiple sclerosis and cancers in Croatia--a possible protective role of the "Mediterranean diet".
    Materljan E; Materljan M; Materljan B; Vlacić H; Barićev-Novaković Z; Sepcić J
    Coll Antropol; 2009 Jun; 33(2):539-45. PubMed ID: 19662776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkinson's disease, multiple sclerosis and changes of residence in Alberta.
    Yiannakoulias N; Schopflocher DR; Warren SA; Svenson LW
    Can J Neurol Sci; 2007 Aug; 34(3):343-8. PubMed ID: 17803035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis.
    Zhang P; Liu B
    ACS Chem Neurosci; 2019 Oct; 10(10):4430-4439. PubMed ID: 31584793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
    Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
    PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancers Preceding Parkinson's Disease after Adjustment for Bias in a Danish Population-Based Case-Control Study.
    Cui X; Liew Z; Hansen J; Lee PC; Arah OA; Ritz B
    Neuroepidemiology; 2019; 52(3-4):136-143. PubMed ID: 30661072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parkinson's and motoneuron disease morbidity in the Twin Cities metropolitan area: 1979-1984.
    Lilienfeld DE; Sprafka JM; Pham DL; Baxter J
    Neuroepidemiology; 1991; 10(3):112-6. PubMed ID: 1922643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
    Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155
    [No Abstract]   [Full Text] [Related]  

  • 49. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
    Alonso A; Logroscino G; Jick SS; Hernán MA
    Eur J Neurol; 2009 Jun; 16(6):745-51. PubMed ID: 19475756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of the demographic, clinical and psychosocial correlates of perceived control in three chronic motor illnesses.
    Eccles FJ; Simpson J
    Disabil Rehabil; 2011; 33(13-14):1065-88. PubMed ID: 21043995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing epidemiology of motor neurone disease in Scotland.
    Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
    J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The width of the third ventricle associates with cognition and behaviour in motor neuron disease.
    Vázquez-Costa JF; Carratalà-Boscà S; Tembl JI; Fornés-Ferrer V; Pérez-Tur J; Martí-Bonmatí L; Sevilla T
    Acta Neurol Scand; 2019 Feb; 139(2):118-127. PubMed ID: 30183086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
    Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
    BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.
    Agalliu I; Ortega RA; Luciano MS; Mirelman A; Pont-Sunyer C; Brockmann K; Vilas D; Tolosa E; Berg D; Warø B; Glickman A; Raymond D; Inzelberg R; Ruiz-Martinez J; Mondragon E; Friedman E; Hassin-Baer S; Alcalay RN; Mejia-Santana H; Aasly J; Foroud T; Marder K; Giladi N; Bressman S; Saunders-Pullman R
    Mov Disord; 2019 Sep; 34(9):1392-1398. PubMed ID: 31348549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer risk in association with Parkinson disease: a population-based study.
    Becker C; Brobert GP; Johansson S; Jick SS; Meier CR
    Parkinsonism Relat Disord; 2010 Mar; 16(3):186-90. PubMed ID: 19945903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa.
    Elian M; Dean G
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):454-7. PubMed ID: 8505633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonfatal cancer preceding Parkinson's disease: a case-control study.
    Elbaz A; Peterson BJ; Yang P; Van Gerpen JA; Bower JH; Maraganore DM; McDonnell SK; Ahlskog JE; Rocca WA
    Epidemiology; 2002 Mar; 13(2):157-64. PubMed ID: 11880756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Swedish motor neuron disease quality registry.
    Longinetti E; Regodón Wallin A; Samuelsson K; Press R; Zachau A; Ronnevi LO; Kierkegaard M; Andersen PM; Hillert J; Fang F; Ingre C
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):528-537. PubMed ID: 30296856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
    Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
    Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.